Organization: Westport Innovations Inc

Diabetogen completes first round financing

Diabetogen Biosciences Inc, London ON, has raised $7.8 million in first-round equity investment to move its technology platform for the treatment of autoimmune diseases towards clinical trials. The firm is currently working towards treatment for Type I diabetes. The financing was provided by the Business Development Bank of Canada Venture Capital Division, VentureLink Group of…